Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Longitudinal Protocol for Eosinophilic Granulomatosis With Polyangiitis
University of Pennsylvania
700 participants
Apr 1, 2006
OBSERVATIONAL
Conditions
Summary
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.
Eligibility
Inclusion Criteria2
- Patients with a diagnosis of eosinophilic granulomatosis with polyangiitis are eligible for the study.
- Parent or guardian willing to provide informed consent, if applicable
Exclusion Criteria1
- \- Inability to give informed consent and to sign the consent form
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(13)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00315380